|
[1] LEE CW, CHEN YF, WU HH, et al. Historical perspectives and advances in mesenchymal stem cell research for the treatment of liver diseases[J]. Gastroenterology, 2018, 154 (1) :46-56.
|
|
[2] WU DB, CHEN EQ, TANG H. Stem cell transplantation for the treatment of end-stage liver disease[J]. World J Hepatol, 2018, 10 (12) :907-910.
|
|
[3] TAO YC, WANG ML, CHEN EQ, et al. Stem cells transplantation in the treatment of patients with liver failure[J]. Curr Stem Cell Res Ther, 2018, 13 (3) :193-201.
|
|
[4] QU ZP, JIA ZF, HUANG X, et al. Research advances in the application of mesenchymal stem cells in organ transplantation[J]. Ogran Transplantation, 2018, 9 (5) :348-353. (in Chinese) 曲泽澎, 贾兆锋, 黄曦, 等.间充质干细胞在器官移植中的应用研究进展[J].器官移植, 2018, 9 (5) :348-353.
|
|
[5] XIAO XX, LIANG R. Research advances in stem cell transplantation for the treatment of acute-on-chronic liver failure[J]. J Clin Hepatol, 2017, 33 (8) :1576-1580. (in Chinese) 肖笑枭, 梁锐.干细胞移植治疗慢加急性肝衰竭的研究进展[J].临床肝胆病杂志, 2017, 33 (8) :1576-1580.
|
|
[6] TANIMOTO H, TERAI S, TARO T, et al. Improvement of liver fibrosis by infusion of cultured cells derived from human bone marrow[J]. Cell Tissue Res, 2013, 354 (3) :717-728.
|
|
[7] HUANG B, CHENG X, WANG H, et al. Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively[J]. J Transl Med, 2016, 14 (1) :45.
|
|
[8] CHAI NL, ZHANG XB, CHEN SW, et al. Umbilical cord-derived mesenchymal stem cells alleviate liver fibrosis in rats[J].World J Gastroenterol, 2016, 22 (26) :6036-6048.
|
|
[9] YAMAZA T, ALATAS FS, YUNIARTHA R, et al. In vivo hepatogenic capacity and therapeutic potential of stem cells from human exfoliated deciduous teeth in liver fibrosis in mice[J].Stem Cell Res Ther, 2015, 6 (1) :171.
|
|
[10] YAMATO M, SAKAI Y, MOCHIDA H, et al. Adipose tissuederived stem cells prevent fibrosis in murine steatohepatitis by suppressing IL-17-mediated inflammation[J]. J Gastroenterol Hepatol, 2019.[Epub ahead of print]
|
|
[11] SASSER AK, SULLIVAN NJ, STUDEBAKER AW, et al. Interleukin-6 is a potent growth factor for ER-alpha-positive human breast cancer[J]. Faseb J, 2007, 21 (13) :3763-3770.
|
|
[12] KARNOUB AE, DASH AB, VO AP, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis[J]. Nature, 2007, 449 (7162) :557-563.
|
|
[13] MATSUURA K, TAKAMI T, MAEDA M, et al. Evaluation of the effects of cultured bone marrow mesenchymal stem cell infusion on hepatocarcinogenesis in hepatocarcinogenic mice with liver cirrhosis[J]. Transplant Proc, 2019, 51 (3) :925-935.
|
|
[14] MOHAMADNEJAD M, ALIMOGHADDAM K, MOHYEDDINBONAB M, et al. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis[J]. Arch Iran Med, 2007, 10 (4) :459-466.
|
|
[15] KHARAZIHA P, HELLSTROM PM, NOORINAYER B, et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection:A phase I-II clinical trial[J]. Eur J Gastroenterol Hepatol, 2009, 21 (10) :1199-1205.
|
|
[16] SUK KT, YOON JH, KIM MY, et al. Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis:Phase 2 trial[J]. Hepatology, 2016, 64 (6) :2185-2197.
|
|
[17] LIN BL, CHEN JF, QIU WH, et al. Allogeneic bone marrowderived mesenchymal stromal cells for hepatitis B virus-related acute-on-chronic liver failure:A randomized controlled trial[J]. Hepatology, 2017, 66 (1) :209-219.
|
|
[18] MOHAMADNEJAD M, ALIMOGHADDAM K, BAGHERI M, et al. Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis[J]. Liver Int, 2013, 33 (10) :1490-1496.
|
|
[19] WANG L, LI J, LIU H, et al. Pilot study of umbilical cord-derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis[J]. J Gastroenterol Hepatol, 2013, 28 (Suppl 1) :85-92.
|
|
[20] ZHANG Z, LIN H, SHI M, et al. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients[J]. J Gastroenterol Hepatol, 2012, 27 (Suppl 2) :112-120.
|
|
[21] KHAN AA, SHAIK MV, PARVEEN N, et al. Human fetal liverderived stem cell transplantation as supportive modality in the management of end-stage decompensated liver cirrhosis[J]. Cell Transplant, 2010, 19 (4) :409-418.
|
|
[22] AMER ME, EL-SAYED SZ, EL-KHEIR WA, et al. Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells[J]. Eur J Gastroenterol Hepatol, 2011, 23 (10) :936-941.
|
|
[23] LEE KD, KUO TK, WHANG-PENG J, et al. In vitro hepatic differentiation of human mesenchymal stem cells[J]. Hepatology, 2004, 40 (6) :1275-1284.
|
|
[24] DI NICOLA M, CARLO-STELLA C, MAGNI M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli[J].Blood, 2002, 99 (10) :3838-3843.
|
|
[25] CORCIONE A, BENVENUTO F, FERRETTI E, et al. Human mesenchymal stem cells modulate B-cell functions[J].Blood, 2006, 107 (1) :367-372.
|
|
[26] SOTIROPOULOU PA, PEREZ SA, GRITZAPIS AD, et al. Interactions between human mesenchymal stem cells and natural killer cells[J]. Stem Cells, 2006, 24 (1) :74-85.
|
|
[27] MILOSAVLJEVIC N, GAZDIC M, SIMOVIC MARKOVIC B, et al. Mesenchymal stem cells attenuate acute liver injury by altering ratio between interleukin 17 producing and regulatory natural killer T cells[J]. Liver Transpl, 2017, 23 (8) :1040-1050.
|
|
[28] LEE KC, LIN HC, HUANG YH, et al. Allo-transplantation of mesenchymal stem cells attenuates hepatic injury through IL1Ra dependent macrophage switch in a mouse model of liver disease[J]. J Hepatol, 2015, 63 (6) :1405-1412.
|
|
[29] BEYTH S, BOROVSKY Z, MEVORACH D, et al. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness[J]. Blood, 2005, 105 (5) :2214-2219.
|
|
[30] EOM YW, SHIM KY, BAIK SK. Mesenchymal stem cell therapy for liver fibrosis[J]. Korean J Intern Med, 2015, 30 (5) :580-589.
|
|
[31] WANG J, BIAN C, LIAO L, et al. Inhibition of hepatic stellate cells proliferation by mesenchymal stem cells and the possible mechanisms[J]. Hepatol Res, 2009, 39 (12) :1219-1228.
|
|
[32] MEIER RP, MAHOU R, MOREL P, et al. Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice[J]. J Hepatol, 2015, 62 (3) :634-641.
|
|
[33] JIN HJ, KWON JH, KIM M, et al. Downregulation of melanoma cell adhesion molecule (MCAM/CD146) accelerates cellular senescence in human umbilical cord blood-derived mesenchymal stem cells[J]. Stem Cells Transl Med, 2016, 5 (4) :427-439.
|
|
[34] SUTO EG, MABUCHI Y, SUZUKI N, et al. Prospectively isolated mesenchymal stem/stromal cells are enriched in the CD73 (+) population and exhibit efficacy after transplantation[J].2017, 7 (1) :4838.
|
|
[35] de WITTE SFH, MERINO AM, FRANQUESA M, et al. Cytokine treatment optimises the immunotherapeutic effects of umbilical cord-derived MSC for treatment of inflammatory liver disease[J]. Stem Cell Res Ther, 2017, 8 (1) :140.
|
|
[36] POURGHOLAMINEJAD A, AGHDAMI N, BAHARVAND H, et al. The effect of pro-inflammatory cytokines on immunophenotype, differentiation capacity and immunomodulatory functions of human mesenchymal stem cells[J]. Cytokine, 2016, 85:51-60.
|
|
[37] REN G, ZHAO X, ZHANG L, et al. Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression[J]. J Immunol, 2010, 184 (5) :2321-2328.
|
|
[38] GHOLAMREZANEZHAD A, MIRPOUR S, BAGHERI M, et al.In vivo tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis[J].Nucl Med Biol, 2011, 38 (7) :961-967.
|
|
[39] PENG L, XIE DY, LIN BL, et al. Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B:Short-term and long-term outcomes[J]. Hepatology, 2011, 54 (3) :820-828.
|
|
[40] WANG K, LI Y, ZHU T, et al. Overexpression of c-Met in bone marrow mesenchymal stem cells improves their effectiveness in homing and repair of acute liver failure[J]. Stem Cell Res Ther, 2017, 8 (1) :162.
|
|
[41] MA HC, SHI XL, REN HZ, et al. Targeted migration of mesenchymal stem cells modified with CXCR4 to acute failing liver improves liver regeneration[J]. World J Gastroenterol, 2014, 20 (40) :14884-14894.
|
DownLoad: